UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)n Fragmentation of Zotepine, Tiaramide and their Metabolites

Drug metabolism and pharmacokinetics, 2002, Vol.17 (4), p.316-339

2002

Volltextzugriff (PDF)

Clinical Stage of Demebtia of Alzheimer's Type

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2001/01/25, Vol.38(1), pp.85-87

Aoba, Anri

2001

Volltextzugriff (PDF)

Plasma quetiapine concentration in predicting the development of extrapyramidal symptoms in schizophrenic patients receiving only quetiapine

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A23

2006

Volltextzugriff (PDF)

The use of antipsychotics in schizophrenic pregnancy

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A26-A27

2006

Volltextzugriff (PDF)

The efficacy for cognitive function of donepezil hydrochloride in Alzheimer-type dementia and its related factors: comparison between medicated and non-medicated groups over 12 months

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A17

2006

Volltextzugriff (PDF)

Regional forum on schizophrenia aiming for rational drug therapy; present activities and future task

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A2-A3

2005

Volltextzugriff (PDF)

Identification and Characterization of the Human Serotonin-4 Receptor Gene Promoter

Biochemical and biophysical research communications, 2001-11, Vol.289 (2), p.337-344

2001

Volltextzugriff (PDF)

Role of physicians and pharmacists in informing patients of psychotropic drugs: survey on quality of life and pharmacotherapy in schizophrenic outpatients

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A27-A28

2006

Volltextzugriff (PDF)

Compliance of psychiatric outpatients: findings of a quality of life and pharmacotherapy survey of schizophrenia outpatients

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A27

2006

Volltextzugriff (PDF)

Relationship between efficacy of risperidone and genetic polymorphism in schizophrenia treatment

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A2

2006

Volltextzugriff (PDF)

Attempting to predict the efficacy of olanzapine by genotype

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A9-A10

2005

Volltextzugriff (PDF)

Comparison of clinical symptoms and cognitive function between before and after switching to olanzapine in schizophrenia patients

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A6

2005

Volltextzugriff (PDF)

Correlations among extra pyramidal symptoms, the perospirone daily dose, the plasma concentrations of perospirone and ID15036, the plasma anti-D2 and anti-5-HT2A activity and anti-5-HT2A/D2 ratio

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A1

2005

Volltextzugriff (PDF)

Comparison of clinical evaluation and cognitive deficit before and after administration of risperidone to patients with schizophrenia

International clinical psychopharmacology, 2004-05, Vol.19 (3), p.180

2004

Volltextzugriff (PDF)

Dosage quantity, plasma risperidone concentration and relationship with clinical effect: contribution of 9-OH-RIS

International clinical psychopharmacology, 2006-07, Vol.21 (4), p.A10-A11

2006

Volltextzugriff (PDF)

The efficacy of the long-term (1-year) use of donepezil hydrochloride in cognitive impairment therapeutic response by severity of Alzheimer-type dementia

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A12

2005

Volltextzugriff (PDF)

Efficacy of novel antipsychotic medications in schizophrenia recurrence prevention

International clinical psychopharmacology, 2005-05, Vol.20 (3), p.A3-A4

2005

Volltextzugriff (PDF)

Relationship between daily dose of atypical antipsychotic and ratio of serotonin (5-HT2A) activity to anti-dopamine (D2) activity (S/D ratio) in plasma - comparison between risperidone and zotepine

International clinical psychopharmacology, 2003-05, Vol.18 (3), p.183

2003

Volltextzugriff (PDF)

A study of drug-induced extrapyramidal symptoms and clinical efficacy in the long-term use of AD-5423 (blonaserin)

International clinical psychopharmacology, 2003-05, Vol.18 (3), p.187-188

2003

Volltextzugriff (PDF)

Dementia induced by antipsychotic drugs

Nihon rinshō, 2004-01, Vol.62 Suppl, p.466

2004

Volltextzugriff (PDF)

Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex

European journal of pharmacology, 1997-08, Vol.333 (2), p.279-287

1997

Volltextzugriff (PDF)

Is chlorpromazine a serotonin-dopamine antagonist (SDA)?

International clinical psychopharmacology, 2001-09, Vol.16 (5), p.304

2001

Volltextzugriff (PDF)

A case of depression with serotonin syndrome undergoing combination of amitoriptyline plus fluvoxamine

International clinical psychopharmacology, 2001-09, Vol.16 (5), p.310

2001

Volltextzugriff (PDF)

2P406 The effects of polymorphism of serotonin receptor on the antipsychotic action of olanzapine

Journal of Pharmacological Sciences, 2003, Vol.91 (suppl.1), p.213-213

2003

Volltextzugriff (PDF)

Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)" Fragmentation of Zotepine. Tiaramide and their Metabolites

DRUG METABOLISM AND PHARMACOKINETICS, 2002, Vol.17 (4), p.316-339

2002

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(44)

Sprache

Englisch
(35)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)n Fragmentation of Zotepine, Tiaramide and their Metabolites

Clinical Stage of Demebtia of Alzheimer's Type

Plasma quetiapine concentration in predicting the development of extrapyramidal symptoms in schizophrenic patients receiving only quetiapine

The use of antipsychotics in schizophrenic pregnancy

The efficacy for cognitive function of donepezil hydrochloride in Alzheimer-type dementia and its related factors: comparison between medicated and non-medicated groups over 12 months

Regional forum on schizophrenia aiming for rational drug therapy; present activities and future task

Identification and Characterization of the Human Serotonin-4 Receptor Gene Promoter

Role of physicians and pharmacists in informing patients of psychotropic drugs: survey on quality of life and pharmacotherapy in schizophrenic outpatients

Compliance of psychiatric outpatients: findings of a quality of life and pharmacotherapy survey of schizophrenia outpatients

Relationship between efficacy of risperidone and genetic polymorphism in schizophrenia treatment

Attempting to predict the efficacy of olanzapine by genotype

Comparison of clinical symptoms and cognitive function between before and after switching to olanzapine in schizophrenia patients

Correlations among extra pyramidal symptoms, the perospirone daily dose, the plasma concentrations of perospirone and ID15036, the plasma anti-D2 and anti-5-HT2A activity and anti-5-HT2A/D2 ratio

Comparison of clinical evaluation and cognitive deficit before and after administration of risperidone to patients with schizophrenia

Dosage quantity, plasma risperidone concentration and relationship with clinical effect: contribution of 9-OH-RIS

The efficacy of the long-term (1-year) use of donepezil hydrochloride in cognitive impairment therapeutic response by severity of Alzheimer-type dementia

Efficacy of novel antipsychotic medications in schizophrenia recurrence prevention

Relationship between daily dose of atypical antipsychotic and ratio of serotonin (5-HT2A) activity to anti-dopamine (D2) activity (S/D ratio) in plasma - comparison between risperidone and zotepine

A study of drug-induced extrapyramidal symptoms and clinical efficacy in the long-term use of AD-5423 (blonaserin)

Dementia induced by antipsychotic drugs

Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex

Is chlorpromazine a serotonin-dopamine antagonist (SDA)?

A case of depression with serotonin syndrome undergoing combination of amitoriptyline plus fluvoxamine

2P406 The effects of polymorphism of serotonin receptor on the antipsychotic action of olanzapine

Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)" Fragmentation of Zotepine. Tiaramide and their Metabolites

Suchergebnisse filtern